Chengzhi Co., Ltd. (SHE:000990)
4.850
+0.010 (0.21%)
Nov 17, 2026, 3:04 PM CST
Chengzhi Revenue
Chengzhi had revenue of 2.27B CNY in the quarter ending September 30, 2026, a decrease of -16.80%. This brings the company's total for the last twelve months to 10.74B, down -6.91% year-over-year. In the year 2025, Chengzhi had annual revenue of 11.03B, down -0.35%. That makes Chengzhi the 5,738th largest company in the world by revenue and 761st in China.
Revenue (ttm)
10.74B
Revenue Growth
-6.91%
P/S Ratio
0.77
Revenue / Employee
2.41M
Employees
4,462
Market Cap
8.25B
Revenue by Segment
- Clean Energy Industry Segment 8.57B 77.1%
- Chemical New Materials Industry 1.63B 14.7%
- Life Sciences Division 728.33M 6.6%
- Other Industry Segment 188.27M 1.7%
Fiscal year ended Dec 31, 2025 See the full Chengzhi breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.03B | -38.43M | -0.35% |
| Dec 31, 2024 | 11.07B | -1.35B | -10.88% |
| Dec 31, 2023 | 12.42B | 700.11M | 5.97% |
| Jan 1, 2023 | 11.72B | -466.63M | -3.83% |
| Jan 1, 2022 | 12.18B | 2.45B | 25.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pacific Shuanglin Bio-pharmacy | 2.42B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 2.16B |
| Vcanbio Cell & Gene Engineering Corp., | 1.38B |
| Liaoning Chengda Biotechnology | 1.34B |
| Shanghai OPM Biosciences | 822.13M |
| Chongqing Genrix Biopharmaceutical | 800.98M |
| Mabwell (Shanghai) Bioscience | 717.80M |
| Hualan Biological Vaccine | 697.41M |